Two new studies that compared antipsychotics seek to fill that gap. The first, which Hamina led, measured the efficacy of ...
New five-year data reinforce long-term safety and efficacy of SPRAVATO® (esketamine) in patients with inadequate response to ...
"MSCI's August 2024 review changes for its standard and small-cap indices will be implemented on Friday, likely leading to $5.5 billion in net inflows," said Sriram Velayudhan, head of alternative ...
July 24, 2024 — Scientists have discovered that the serrated edges of Komodo dragons' teeth are tipped with iron. The study gives new insight into how Komodo dragons keep their teeth razor-sharp ...
Since they were not qualified to administer his now three-day overdue paliperidone injection, they provided him with a safety plan, advising him to take olanzapine overnight and to avoid alcohol ...
A screenshot of the ABC News-hosted presidential debate between Kamala Harris and Donald Trump in September 2024. Picture: Youtube screenshot of Wall Street Journal debate stream Half of the world ...
Examples of the long-acting antipsychotics include paliperidone, sold under Invega Sustenna and other brand names, and risperidone, sold under Perseris and other brand names The cost impact of LAIs ...
Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received final approval from the United States Food and Drug Administration (USFDA) ...
Shares of Neuland Laboratories Ltd. saw its shares jump 15% to a record high, driven by a surge in export revenues, according to an analyst note. The company reported exports totaling $27 million for ...
Zydus Lifesciences has received the USFDA's final approval to produce a generic version of Paliperidone extended-release tablets, which are used to treat schizophrenia and schizoaffective disorders.
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Paliperidone extended-release tablets. Paliperidone extended ...
Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its generic version of Paliperidone extended-release tablets, used to treat ...